ABT ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 31, 2022 in the Class Action Filed on Behalf of Abbott Laboratories Limited ShareholdersNewsfile Corp • 09/13/22
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Abbott Laboratories (ABT) Investors of Class Action and to Actively ParticipateBusiness Wire • 09/13/22
Abbott Laboratories Stock: Abbott Shareholders Are Encouraged to Contact Kehoe Law Firm, P.C. to Discuss Potential Legal ClaimsNewsfile Corp • 09/13/22
ABT LAWSUIT FILED: Jakubowitz Law Pursues Claims on Behalf of ABBOTT LABORATORIES ShareholdersNewsfile Corp • 09/13/22
INVESTOR NOTICE: Abbott Laboratories Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ABTNewsfile Corp • 09/13/22
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Abbott Laboratories of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 31, 2022 - (ABT)Newsfile Corp • 09/12/22
ABT INVESTOR NOTICE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABTPRNewsWire • 09/12/22
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the FirmNewsfile Corp • 09/12/22
2 Dividend Aristocrats to Buy for Passive Income That Could Outperform the MarketThe Motley Fool • 09/12/22
Pick Either Johnson & Johnson Stock Or This Healthcare Company – Both Are Likely To Offer Similar ReturnsForbes • 09/12/22
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABTNewsfile Corp • 09/11/22
INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the FirmNewsfile Corp • 09/09/22
ABT INVESTOR NOTICE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABTNewsfile Corp • 09/09/22
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Abbott Laboratories (ABT) Investors with Significant Losses to Contact Firm's Attorneys, Infant Formula-Related Securities Fraud Class Action FiledPRNewsWire • 09/08/22
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the FirmNewsfile Corp • 09/08/22
Three-Year Data on World's Smallest Heart Device Show Benefits of Fixing Holes in Newborn Hearts Without SurgeryPRNewsWire • 09/08/22
ABBOTT LABORATORIES (ABT) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Abbott Laboratories (ABT)Newsfile Corp • 09/08/22
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the FirmNewsfile Corp • 09/07/22
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Abbott Laboratories Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – ABTBusiness Wire • 09/05/22
ROSEN, A LEADING LAW FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABTPRNewsWire • 09/04/22
INVESTOR NOTICE: Abbott Laboratories Investors with Substantial Losses Have Opportunity to Lead the Abbott Laboratories Class Action Lawsuit - ABTPRNewsWire • 09/03/22
